Whatsapp

Kabimethate 3Million IU Powder for Injection

image-load

Kabimethate 3Million IU Powder for Injection

Introduction to Kabimethate 3Million IU Powder for Injection

Kabimethate 3Million IU Powder for Injection belongs to the polymyxin group, is an antibiotic used to combat certain types of bacterial infections. It works by disrupting the protective outer layer of specific bacteria, causing significant harm to their structure, and is selective in its action against these bacteria.

Colistimethate Sodium, a type of polymyxin, disturbs the protective outer layer of bacteria, effectively damaging their structure. It specifically targets bacteria with a particular outer layer, rendering it a potent defender against these harmful bacteria.

This medication will be provided by your doctor or nurse; self-administration is not recommended. Trust your healthcare professional to administer the medicine. Avoid self-administration and wait for guidance from your doctor or nurse.

Possible side effects may include upset stomach, dizziness, tingling sensation (paresthesia), vertigo, rash, and fever.

Colistimethate Sodium can potentially cause kidney damage (nephrotoxicity), especially at higher doses or prolonged use. Close monitoring for signs of kidney dysfunction is crucial. Additionally, it may interfere with neuromuscular transmission, so caution is advised in patients receiving muscle relaxants.

Your doctor or nurse will closely monitor your dosing schedule. Missing a dose is rare, but if you suspect you have missed one, inform them promptly to ensure you receive the appropriate treatment at the correct time.

Related Faqs

Written By:

about-us.jpg

Published At: Oct 19, 2023

Updated At: Sep 19, 2024

Reviewed By:

about-us.jpg

Published At: Oct 19, 2023

Updated At: Sep 19, 2024

Disclaimer : This information is not a substitute for medical advice. Consult your healthcare provider before making any changes to your treatment . Do not ignore or delay professional medical advice based on anything you have seen or read on Medwiki.